Carboplatin and doxorubicin in treatment of pediatric osteosarcoma: A 9-year single institute experience in the northern region of Thailand

• المؤلفون الرئيسيون: Worawut Choeyprasert, Rungrote Natesirinilkul, Pimlak Charoenkwan, Somjai Sittipreechacharn
• التنسيق: دورية
• منشور في: 2018
• الوصول للمادة أونلاين: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84877637233&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/48213

Background: Osteosarcoma is the most common primary bone tumor in childhood and adolescence. Carboplatin, a platinum-derived agent, is used as neoadjuvant chemotherapy for pediatric osteosarcoma because of its anti-tumor activity and had low toxicity as compared to cisplatin. Objective: To determine...